Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $1,257,696 (100.0% shares, 0.0% debt)

Holdings (14)

ALKS Alkermes PLC 23.1%

Value ($000) $291,052 Shares 11,870,000 Est. Cost $19.87 Unrealized +12.0%

BIIB BIOGEN INC 17.7%

Value ($000) $222,651 Shares 643,000 Est. Cost $278.12 Unrealized +8.9%

IRWD IRONWOOD PHARMACEUTICALS INC 16.8%

Value ($000) $210,939 Shares 16,390,000 Est. Cost $11.52 Unrealized -0.6%

GILD Gilead Sciences Inc 14.8%

Value ($000) $185,742 Shares 2,697,400 Est. Cost $53.36 Unrealized +4.7%

— Alexion Pharmaceuticals Inc 9.5%

Value ($000) $119,492 Shares 650,440 Est. Cost $108.59 Unrealized —

INVA INNOVIVA INC 6.8%

Value ($000) $86,011 Shares 6,414,000 Est. Cost $13.01 Unrealized -3.8%

BCRX BioCryst Pharmaceuticals Inc 5.4%

Value ($000) $67,366 Shares 4,261,000 Est. Cost $4.60 Unrealized +195.4%

— MERSANA THERAPEUTICS INC 4.3%

Value ($000) $54,396 Shares 4,005,600 Est. Cost $9.57 Unrealized —

— VOR BIOPHARMA INC 1.0%

Value ($000) $13,186 Shares 707,010 Est. Cost $43.10 Unrealized —

— SARISSA CAPITAL ACQUISITN CO 0.4%

Value ($000) $4,999 Shares 3,333,333 Est. Cost $1.50 Unrealized —

— REGULUS THERAPEUTICS INC 0.1%

Value ($000) $1,506 Shares 1,851,851 Est. Cost $1.25 Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 0.0%

Value ($000) $177 Shares 1,000 Est. Cost $128.37 Unrealized +34.9%

— MIRATI THERAPEUTICS INC 0.0%

Value ($000) $161 Shares 1,000 Est. Cost $42.00 Unrealized —

— INTERCEPT PHARMACEUTICALS INC 0.0%

Value ($000) $18 Shares 950 Est. Cost $79.88 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	Alkermes PLC	11,870,000	$291,052	23.1%	$19.87	+12.0%	SHS	G01767105
BIIB	BIOGEN INC	643,000	$222,651	17.7%	$278.12	+8.9%	COM	09062X103
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$210,939	16.8%	$11.52	-0.6%	COM CL A	46333X108
GILD	Gilead Sciences Inc	2,697,400	$185,742	14.8%	$53.36	+4.7%	COM	375558103
—	Alexion Pharmaceuticals Inc	650,440	$119,492	9.5%	$108.59	—	COM	015351109
INVA	INNOVIVA INC	6,414,000	$86,011	6.8%	$13.01	-3.8%	COM	45781M101
BCRX	BioCryst Pharmaceuticals Inc	4,261,000	$67,366	5.4%	$4.60	+195.4%	COM	09058V103
—	MERSANA THERAPEUTICS INC	4,005,600	$54,396	4.3%	$9.57	—	COM	59045L106
—	VOR BIOPHARMA INC	707,010	$13,186	1.0%	$43.10	—	COM	929033108
—	SARISSA CAPITAL ACQUISITN CO	3,333,333	$4,999	0.4%	$1.50	—	W EXP 10/23/202	G7823W110
—	REGULUS THERAPEUTICS INC	1,851,851	$1,506	0.1%	$1.25	—	COM NEW	75915K200
JAZZ	JAZZ PHARMACEUTICALS PLC	1,000	$177	0.0%	$128.37	+34.9%	SHS USD	G50871105
—	MIRATI THERAPEUTICS INC	1,000	$161	0.0%	$42.00	—	COM	60468T105
—	INTERCEPT PHARMACEUTICALS INC	950	$18	0.0%	$79.88	—	COM	45845P108